Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1035620170050040185
Allergy Asthma & Respiratory Disease
2017 Volume.5 No. 4 p.185 ~ p.192
The KAAACI Standardization Committee Report on the procedure and application of fractional exhaled nitric oxide measurement
Kwon Jae-Woo

Song Woo-Jung
Kim Min-Hye
Lim Kyung-Hwan
Yang Min-Suk
Jung Jae-Woo
Lee Jeong-Min
Suh Dong-In
Shin Yoo-Seob
Kim Sae-Hoon
Kim Sang-Heon
Lee Byung-Jae
Cho Sang-Heon
Abstract
Fractional exhaled nitric oxide (FeNO) is a biomarker for type 2 inflammation in the airways, and its measurement has the distinct strengths of being simple, rapid, convenient, and reproducible. Since the discovery of FeNO in the 1990s, its measurement tools have been extensively developed and validated by several researchers. In particular, FeNO showed the potential to support the diagnosis of asthma and eosinophilic bronchitis. Since it has begun to be widely utilized in clinical research areas as well as daily practice, we summarized the standardized diagnostic procedures and suggested the clinical application of FeNO measurement in Korean population.
KEYWORD
Nitric oxide, Diagnostic techniques and procedures, Asthma, Reference standards
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI) KoreaMed